Tech Company Financing Transactions
Profusa Funding Round
Profusa, based in San Francisco, secured $45 million from 3E Bioventures, Atinum Investment and Maxim Ventures.
Transaction Overview
Company Name
Announced On
8/15/2018
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series C
Investors
Proceeds Purpose
Profusa plans to use the proceeds from this financing to advance the commercialization of its first product on the market -- the Profusa Lumee Oxygen Platform for continuous, real-time monitoring of tissue oxygen -- and to accelerate the development of its transformative glucose biosensor technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2325 3rd St. 344
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Profusa, Inc. manufactures tissue-integrated sensors and biosensors that help in diabetes management. The company was incorporated in 2009 and is based in San Francisco, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
William McMillan
Browse more venture capital transactions:
Prev: 8/15/2018: Ubiquity6 venture capital transaction
Next: 8/15/2018: Capillary Biomedical venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs